CLYM NASDAQ
Climb Bio, Inc.
1W: -3.7%
1M: +17.3%
3M: +93.8%
YTD: +190.9%
1Y: +779.8%
$11.00
+0.09 (+0.82%)
Weekly Expected Move ±12.3%
$8
$9
$11
$12
$13
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.8M
Congress—
ETF Holdings—
Key Statistics
Market Cap$750.0M
52W Range1.16-12.48
Volume467,199
Avg Volume701,615
Beta0.05
Dividend—
Analyst Ratings
Company Info
CEOAoife Brennan BCh MMSc
Employees17
SectorHealthcare
IndustryBiotechnology
IPO Date2021-08-10
Websiteeliemtx.com
PMB #117, 2801 Centerville Road
Wellesley Hills, DE 19808-1609
US
Wellesley Hills, DE 19808-1609
US
866 857 2596
About Climb Bio, Inc.
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Latest News
Climb Bio to Present at Upcoming Investor Conferences
Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts
Climb Bio raises $110M in private placement; shares up
Climb Bio raises $110M in private placement; shares up
Climb Bio raises $110M in private placement; shares up
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Thomas Stephen Basil | S-Sale | 16,313 | $7.01 | 2026-02-26 |
| Thomas Stephen Basil | S-Sale | 33,687 | $7.00 | 2026-02-25 |
| Thomas Stephen Basil | S-Sale | 10,000 | $5.81 | 2026-02-13 |
| Thomas Stephen Basil | S-Sale | 90,000 | $5.23 | 2026-02-12 |
| Brennan Aoife | A-Award | 700,000 | $3.81 | 2026-01-06 |